This inventor holds 2 USPTO granted patents. Top assignee: Beecham Group Plc. Active years: 1992.
Location History:
- Epsom, GB (1992)
- Epson, GB (1992)
Company Filing History:
Years Active: 1992
Title: The Innovations of William S MacLachlan
Introduction
William S MacLachlan is a notable inventor based in Epsom, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating fungal infections. With a total of 2 patents to his name, his work has had a meaningful impact on medical science.
Latest Patents
MacLachlan's latest patents include innovative derivatives of Amphotericin B. The first patent describes compounds of formula (I) or salts thereof, where each R₁ is independently hydrogen or a silyl protecting group. R₂ can be a carboxylic acid or derivative, a ketone or aldehyde function, or hydroxymethyl, among other substitutions. These compounds are noted for their use as chemical intermediates and in the treatment of fungal infections. The second patent focuses on 16-decarboxy-16-hydroxy derivatives of Amphotericin B, detailing their preparation, compositions, and therapeutic applications.
Career Highlights
William S MacLachlan has been associated with Beecham Group Plc, where he has contributed to various research initiatives. His work has been pivotal in advancing pharmaceutical formulations that address critical health issues.
Collaborations
MacLachlan has collaborated with notable colleagues, including Michael J Driver and David T MacPherson. Their combined expertise has fostered innovation in the field of medicinal chemistry.
Conclusion
William S MacLachlan's contributions to pharmaceutical inventions, particularly in the area of antifungal treatments, underscore his role as a significant inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.